Bitcoin and Ethereum Extend Losses Amid Macro Headwinds Triggering Over 400 Million in Market Liquidations Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Performance SiTime Corporations Market Position A Potential Multibagger Candidate 83YearOld Widow Confronts Credit Void After Husbands Death A Legacy of Financial Dependence Maxim Group Upgrades Gilead Sciences to Buy Potential Signal of Optimism Italian Diving Tragedy Highlights Potential Risks of Inadequate Equipment in Extreme Environments CFR Q1 2026 Earnings Solid EPS Beat Amid Stable Performance SCCE Q4 2025 Earnings EPS Surges Past Estimates on Solid Performance NRP Q1 2026 Earnings LP Reports Solid EPS Amid Quiet Market Response Stardust Power Inc SDST Q1 2026 Earnings Wider Loss Meets Strategic Milestones as Stock Surges ODD Q4 2025 Earnings Earnings Beat on Strong EPS Surprise AKBA Q1 2026 Earnings EPS Misses Estimates Amid Operational Developments Biofrontera Inc Warrants BFRIW Surge Over 19 as Speculative Interest Returns Oxford Lane Capital Corp 875 Notes 2030 OXLCI Modest Gain Amid Stable Yield Positioning Advance Auto Parts AAP Rebounds Stock Rises 276 Eyes Resistance Corporacion America Airports CAAP Faces Resistance at 2621 Amid Slight Pullback Hyperion DeFi Inc HYPD Slips 24 as Selling Pressure Intensifies Key Support Levels in Focus Pet Supplies Chain Files Chapter 11 Bankruptcy QuinStreet Q1 2026 Earnings EPS Misses Estimates Stock Gains 24 Donegal Group Inc DGICB Holds Steady at 1895 as Key Support and Resistance Levels Define Trading Range TPG Q1 2026 Earnings EPS Beats Estimates by 14 Stock Edges Lower Zevia PBC ZVIA Q1 2026 Earnings Narrowerthanexpected loss drives stock surge POWW Q1 2026 Earnings Profitability Surprise as EPS Turns Positive BKD Q1 2026 Earnings EPS Misses Estimates as Occupancy Headwinds Persist PM Q1 2026 Earnings Earnings Beat on Margin Strength SmokeFree Momentum Continues EML Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Uptick STOK Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances